These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 704994)

  • 1. [Incidence of e antigen and antibody in acute and chronic HBsAg (+) liver diseases].
    San Miguel Joglar G; Rodríguez de Lope C; Pérez Fuenzalida F; Pons Romero F
    Rev Clin Esp; 1978 Jul; 150(1-2):67-9. PubMed ID: 704994
    [No Abstract]   [Full Text] [Related]  

  • 2. [HBe Ag/anti-HBe system: results of a study of 66 patients having the hepatitis B surface antigen (HBsAG)].
    Lemaire JM; Borgeot C; Mourrut C; Michel H
    Nouv Presse Med; 1978 Sep; 7(32):2878. PubMed ID: 714681
    [No Abstract]   [Full Text] [Related]  

  • 3. Study of antibody to hepatitis-B virus core antigen (anti-HBc) in chronic diffuse liver disease.
    Dávid K; Halmy L
    Acta Med Acad Sci Hung; 1982; 39(3-4):161-8. PubMed ID: 7185241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High titre of antibody to hepatitis B core antigen detected by immune adherence haemagglutination in HBsAg-positive acute hepatitis.
    Ikegami F; Takasu S; Jo K; Miyakawa Y; Tsuda F; Mayumi M
    Hepatogastroenterology; 1982 Aug; 29(4):142-3. PubMed ID: 7129336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antibodies against e-antigen in patients with HBsAg-positive liver diseases].
    Thamer G; Gmelin K; Kommerell B
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():557-8. PubMed ID: 612030
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical significance of HBeAg and anti-HBe in HBsAg positive liver diseases].
    Takahashi A; Sekiya C; Yazaki Y; Tominaga Y; Oohara K; Ono M; Sato H; Hasebe C; Namiki M
    Hokkaido Igaku Zasshi; 1983 Jan; 58(1):30-42. PubMed ID: 6840666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Relationship between primary carcinoma of the liver and Australia antigen or anti-Australia HB antigen in Greece].
    Theodoropoulos G; Economopoulos P; Archimandritis A; Melissinos K
    Nouv Presse Med; 1977 Feb; 6(8):654. PubMed ID: 866166
    [No Abstract]   [Full Text] [Related]  

  • 8. [The presence and significance of HBe antigens and anti-HBe antibodies in HBs antigen positive patients].
    Zivanović-Marinković V; Kaljalović R; Marinković V; Dumović B; Lazarov A; Nanusević N; Krstić L; Parabucki S
    Zb Vojnomed Akad; 1981; 23():24-6. PubMed ID: 6963836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The behavior of the HBeAg-anti-HBe system in chronic hepatitis].
    Musca A; Cordova C; Barnaba V; Bonavita MS; Zaccari C; Levrero M
    Minerva Dietol Gastroenterol; 1983; 29(1):19-26. PubMed ID: 6843853
    [No Abstract]   [Full Text] [Related]  

  • 10. Hepatitis Be antigen and antibody in chronic liver diseases and hepatocellular carcinoma.
    Chen DS; Sung JL; Lai MY
    Hepatogastroenterology; 1981 Dec; 28(6):288-91. PubMed ID: 6284625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prevalence of surface antigens (HBsAg), surface antibody (HBsAb) and anticore antibody (HBcAb) in hospital personnel and patients with and without hepatic pathology].
    Ardito D; Bianco T; Demundo T; Loiodice L
    Minerva Med; 1980 Oct; 71(39):2815-20. PubMed ID: 7432690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HBeAg/anti-HBe system in the acute phase of HBsAg-positive hepatitis as a predictive test of developing chronic hepatitis.
    Caredda F; D'Arminio Monforte A; Rossi E; Cultraro D; Marescotti C; Moroni M
    Boll Ist Sieroter Milan; 1981; 60(6):468-79. PubMed ID: 7344717
    [No Abstract]   [Full Text] [Related]  

  • 13. [Antibodies against hepatitis B virus in chronic non-alcoholic HBsAg-negative hepatopathies].
    Moreira Vicente VF; Simón Marco MA; Pascasio Acevedo JM; Ruiz del Arbol Olmos L; Larraona Moreno JL; González Martín JA; Aguilera Musso D; Barcena Marugan R; Bueno Vallejo R
    Med Clin (Barc); 1984 Mar; 82(12):522-30. PubMed ID: 6738151
    [No Abstract]   [Full Text] [Related]  

  • 14. Hepatitis B viral markers in patients with primary hepatocellular carcinoma in Taiwan.
    Chien MC; Tong MJ; Lo KJ; Lee JK; Milich DR; Vyas GN; Murphy BL
    J Natl Cancer Inst; 1981 Mar; 66(3):475-9. PubMed ID: 6162990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis B surface antigen (HBsAg) and its antibody (HBsAb) among dentists and auxiliary personnel in Virginia.
    Escobar MR; Syrop HM; Fisher LM; Swenson PD; Blanke RV; Fletcher CF
    Va Dent J; 1978 Jun; 55(3):22-7. PubMed ID: 287295
    [No Abstract]   [Full Text] [Related]  

  • 16. [Search for viral hepatitis B antigen (HBsAg) and its antibodies in the sera of rheumatism patients].
    Budnitskaia PZ; Borodiiuk NA; Liampert IM
    Vopr Revm; 1979; (4):22-4. PubMed ID: 316609
    [No Abstract]   [Full Text] [Related]  

  • 17. [Viral markers of hepatitis A and B: main characteristics and clinical significance].
    Lyra LG
    Arq Gastroenterol; 1983; 20(3):117-22. PubMed ID: 6329145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [e/Anti-e system in liver disease].
    Resta ML; Freni MA; Berlinghieri G; Ajello A; Crinò M; Ferraù O
    Boll Soc Ital Biol Sper; 1980 Oct; 56(20):2123-8. PubMed ID: 7459125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prevalence of the surface antigen of the hepatitis type B virus (HBsAg) in chronic hepatic disease].
    Ocaña Andrade E; Valverde Castañeda N; Garrido Palma J; Carrillo Cambero JL
    Rev Gastroenterol Mex; 1985; 50(1):19-22. PubMed ID: 4089439
    [No Abstract]   [Full Text] [Related]  

  • 20. [Simultaneous investigation of surface antigen and antibody of hepatitis B virus using the RIA QUICK HBsAg, anti-HBs kit (author's transl)].
    Kselíková M; Novák J; Urbánková J
    Cas Lek Cesk; 1982 Mar; 121(11):339-42. PubMed ID: 7066943
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.